NGM Biopharmaceuticals, Inc. EBITDA Margin 2018-2023 | NGM

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for NGM Biopharmaceuticals, Inc. (NGM) over the last 10 years. The current EBITDA margin for NGM Biopharmaceuticals, Inc. as of December 31, 2023 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $0.00B $-0.16B -3875.00%
2023-09-30 $0.02B $-0.16B -745.45%
2023-06-30 $0.03B $-0.18B -620.69%
2023-03-31 $0.04B $-0.18B -508.33%
2022-12-31 $0.06B $-0.16B -296.36%
2022-09-30 $0.06B $-0.15B -256.90%
2022-06-30 $0.07B $-0.13B -184.06%
2022-03-31 $0.08B $-0.12B -148.72%
2021-12-31 $0.08B $-0.11B -140.51%
2021-09-30 $0.08B $-0.11B -143.59%
2021-06-30 $0.08B $-0.11B -139.02%
2021-03-31 $0.09B $-0.10B -122.35%
2020-12-31 $0.09B $-0.10B -111.49%
2020-09-30 $0.10B $-0.09B -88.78%
2020-06-30 $0.10B $-0.07B -72.16%
2020-03-31 $0.10B $-0.05B -52.94%
2019-12-31 $0.10B $-0.04B -41.35%
2019-09-30 $0.12B $-0.01B -10.00%
2019-06-30 $0.12B $-0.01B -6.72%
2019-03-31 $0.12B $-0.00B -2.59%
2018-12-31 $0.11B $0.00B 1.83%